Recurrent respiratory infections

Recurrent respiratory infections are a common clinical concern, particularly in children, the elderly, and immunocompromised individuals. They may result from structural lung abnormalities, immune deficiencies, chronic diseases, or persistent environmental exposures. Patients often present with repeated episodes of pneumonia, bronchitis, or sinusitis, which can impair lung function over time and increase healthcare utilization. Comprehensive evaluation involves detailed history, imaging studies, immune function testing, and microbiological analysis to identify underlying predisposing factors. Management strategies depend on etiology but often include vaccination, antimicrobial prophylaxis, and optimization of comorbidities such as asthma or diabetes. For individuals with impaired airway clearance, physiotherapy and mucolytic agents improve secretion removal, reducing infection risk. Advances in immunology are paving the way for targeted therapies, including immunoglobulin replacement in patients with antibody deficiencies and biologics for those with inflammatory comorbidities. Preventive measures such as improved nutrition, environmental control, and smoking cessation also contribute significantly to reducing recurrence. Recurrent respiratory infections require coordinated care involving pulmonologists, immunologists, and infectious disease specialists. Emerging research on host-microbe interactions and microbiome modulation offers new insights into prevention and treatment. By focusing on early detection, tailored therapy, and long-term preventive strategies, clinicians can minimize complications and improve overall lung health in vulnerable populations.